---
figid: PMC9581181__fphys-13-1019028-g002
figtitle: Ion channels as a therapeutic target for renal fibrosis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Escherichia coli
- Drosophila melanogaster
- Xenopus laevis
- Adeno-associated virus
- Saccharina japonica
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Xenopus laevis
pmcid: PMC9581181
filename: fphys-13-1019028-g002.jpg
figlink: /pmc/articles/PMC9581181/figure/F2/
number: F2
caption: 'Regulation of CRAC, P2XR, TRP channels. (1) GPCR activates PLC, then further
  decompose the phosphorylated PIP2 into DAG and IP3. IP3 acts on IP3R on the ER,
  triggering Ca2+ release leading to depletion, which is sensed by STIM and then binds
  and activates the ORAI pore-forming channel CRAC, facilitating Ca2+ entry. Enhanced
  Ca2+ promotes the phosphorylation of Smad2/3 to enhance the TGF-β1 signaling pathway,
  and binds to calcineurin and promotes NFAT activity. (2) Activated P2X7R induces
  NLRP3 inflammasome activation by K+ efflux and catalyzes pro-IL -1β cleavage to
  IL-1β, which not only promotes the TGF signaling pathway but also enhances c-myc
  transcriptional enhancement of fibrosis. (3) TRPC6 promotes the fibrotic process
  by enhancing AKT-mTOR and ERK1/2 pathways as well as the calcineurin/NFAT pathway.
  DAG: diacylglycerol; GPCR: G protein coupled receptor; IP3: 1, 4, 5-triphosphoinositol;
  IP3R: inositol 1,4,5-triphate receptor; PIP2: phosphorylated phosphatidylinositol
  4, 5-diphosphate; PLC: phospholipase C; NFATs: nuclear factor of activated T cells;
  IL-1β: Interleukin-1β; NLRP3: nucleotide-binding oligomerization domain-like receptor
  family pyrin domain-containing-3.'
papertitle: Ion channels as a therapeutic target for renal fibrosis.
reftext: Peng Yan, et al. Front Physiol. 2022;13:1019028.
year: '2022'
doi: 10.3389/fphys.2022.1019028
journal_title: Frontiers in Physiology
journal_nlm_ta: Front Physiol
publisher_name: Frontiers Media S.A.
keywords: ion channels | renal fibrosis | kidney | Cl− channels | Ca2+ signaling |
  K+ channels | Na+ transport
automl_pathway: 0.937571
figid_alias: PMC9581181__F2
figtype: Figure
redirect_from: /figures/PMC9581181__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9581181__fphys-13-1019028-g002.html
  '@type': Dataset
  description: 'Regulation of CRAC, P2XR, TRP channels. (1) GPCR activates PLC, then
    further decompose the phosphorylated PIP2 into DAG and IP3. IP3 acts on IP3R on
    the ER, triggering Ca2+ release leading to depletion, which is sensed by STIM
    and then binds and activates the ORAI pore-forming channel CRAC, facilitating
    Ca2+ entry. Enhanced Ca2+ promotes the phosphorylation of Smad2/3 to enhance the
    TGF-β1 signaling pathway, and binds to calcineurin and promotes NFAT activity.
    (2) Activated P2X7R induces NLRP3 inflammasome activation by K+ efflux and catalyzes
    pro-IL -1β cleavage to IL-1β, which not only promotes the TGF signaling pathway
    but also enhances c-myc transcriptional enhancement of fibrosis. (3) TRPC6 promotes
    the fibrotic process by enhancing AKT-mTOR and ERK1/2 pathways as well as the
    calcineurin/NFAT pathway. DAG: diacylglycerol; GPCR: G protein coupled receptor;
    IP3: 1, 4, 5-triphosphoinositol; IP3R: inositol 1,4,5-triphate receptor; PIP2:
    phosphorylated phosphatidylinositol 4, 5-diphosphate; PLC: phospholipase C; NFATs:
    nuclear factor of activated T cells; IL-1β: Interleukin-1β; NLRP3: nucleotide-binding
    oligomerization domain-like receptor family pyrin domain-containing-3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trpc6
  - Akt1
  - Mtor
  - Tas2r134
  - Rxfp2
  - Cat
  - Mapk3
  - Mapk1
  - Orai1
  - Map2k1
  - Jun
  - Fos
  - Smad3
  - Smad2
  - Il18
  - Il13
  - Myc
  - Nlrp3
  - Nfkb1
  - Trpm7
  - Trpv1
  - Gpbar1
  - Hspg2
  - Itpr1
  - cac
  - Mip
  - Trpv6
  - Glyat
  - Tmem132a
  - Nol3
  - TRPC6
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ITPR1
  - ITPR3
  - CAT
  - CRAT
  - GLYAT
  - MAPK3
  - MAPK1
  - ORAI1
  - MAP2K1
  - JUN
  - FOS
  - GATA4
  - FEZF2
  - SMAD3
  - SMAD2
  - IL18
  - IL13
  - MYC
  - NLRP3
  - ATP8A2
  - NFKB1
  - MUC7
  - MCOLN1
  - TRPM7
  - TRPV1
  - Akt
  - Tor
  - Oamb
  - mod
  - mod(mdg4)
  - rsd
  - norpA
  - sl
  - Plc21C
  - Itpr
  - Ca-alpha1T
  - ChAT
  - sv
  - rl
  - Orai
  - Stim
  - tim
  - Jra
  - kay
  - Smox
  - ATPsynbeta
  - Atpalpha
  - Dif
  - dl
  - Rel
  - trhr.S
  - trhr2.L
  - nmur1.L
  - gprc6a.L
  - nmur1.S
  - hspg2.L
  - itpr1.S
  - itpr1.L
  - cat.2.L
  - cat.1.L
  - mapk1.L
  - mapk1.S
  - orai1.S
  - orai2.S
  - map2k1.S
  - ppp3ca.S
  - ppp3ca.L
  - jun.S
  - jun.L
  - fos.S
  - fos.L
  - smad3.L
  - smad3.S
  - smad2.L
  - smad2.S
  - il18.S
  - il18.L
  - myc.S
  - myc.L
  - nlrp3.L
  - nfkb1.L
  - nfkb1.S
  - trpm7.L
  - trpv1.S
---
